Meta-analysis of 417 relapsing patients in five paliperidone withdrawal trials: rapid relapse was no more common on placebo than on continued drug (injectable 20% vs 11%, p=0.12; oral 27% vs 26%) and was linked to higher baseline symptom severity.
Meta-analysisn = 417
Louie et al. Relapse trajectories and antipsychotic discontinuation in schizophrenia from individual participant data of five trials from the Yale Open Data Access database: a meta-analysis